Among the various public portfolio startups of the fund, we may underline Poseida Therapeutics Among the most successful fund investment fields, there are Biotechnology, Medical Device.
The important activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of more than 100 millions dollars.
The standard case for the fund is to invest in rounds with 9 partakers. Despite the Pentwater Capital Management, startups are often financed by Malin Corporation, Vivo Capital, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Rapha Capital Management, Perceptive Advisors.
The overall number of key employees were 1.
| Fund Name | Location |
| Crestview Capital | Illinois, United States, Winnetka |
| Crestview Partners | New York, New York, United States |
| eCAP Holdings LLC | Dallas, Texas, United States |
| Encompass Ventures | Kirkland, United States, Washington |
| Four Lane Investment Partnership | - |
| Hancock Bank | - |
| Jornic Ventures | - |
| Karolinska | Solna, Stockholms Lan, Sweden |
| Kopf &Capital | Baden-Wurttemberg, Germany, Mannheim |
| MFS Africa | Gauteng, Johannesburg, South Africa |
| Milestone Capital China | China, Shanghai, Shanghai |
| Ningbo Huitian Hede Xinxi | China, Ningbo, Zhejiang |
| Provence Business Angels | France, Marseille, Provence-Alpes-Cote d'Azur |
| Runwu Konggu | Beijing, China, Haidian |
| Silverfern Group | New York, New York, United States |
| Taiyo Kogyo | Japan, Setagaya |
| Win Fund | Canada, Ontario, Ottawa |
| Work Play Ventures | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Poseida Therapeutics | $142M | 22 Apr 2019 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Poseida Therapeutics | $142M | 22 Apr 2019 | San Diego, California, United States |
